GenBank accession no. | Symbol | Description | Avg. control | Avg. patients | Ratio C/P |
---|---|---|---|---|---|
NM_001145 | ANG | Angiogenin, ribonuclease, RNase A family, 5 | 18.8 | 6.1 | 3.1 |
NM_000041 | APOE | Apolipoprotein E | 16.9 | 7.2 | 2.3 |
NM_002983 | CCL3 | chemokine (C-C motif) ligand 3 | 166.7 | 7.4 | 22.4 |
D90145 | CCL3L1 | chemokine (C-C motif) ligand 3-like 1 | 197.7 | 21.4 | 9.2 |
NM_002984 | CCL4 | chemokine (C-C motif) ligand 4 | 221.7 | 22.2 | 10.0 |
NM_002985 | CCL5 | chemokine (C-C motif) ligand 5 | 38.5 | 8.3 | 4.7 |
NM_001781 | CD69 | CD69 antigen (p60, early T-cell activation antigen) | 23.5 | 4.5 | 5.2 |
NM_004233 | CD83 | CD83 antigen (activated B lymphocytes, immunoglobulin superfamily) | 24.3 | 0.1 | 365.9 |
NM_031226 | CYP19A1 | cytochrome P450, family 19, subfamily A, polypeptide 1 | 25.8 | 9.2 | 2.8 |
NM_004408 | DNM1 | Dynamin 1 | 13.6 | 4.1 | 3.3 |
NM_004418 | DUSP2 | Dual specificity phosphatase 2 | 54.1 | 7.8 | 6.9 |
NM_000114 | EDN3 | Endothelin 3 | 36.7 | 11.8 | 3.1 |
NM_001961 | EEF2 | Eukaryotic translation elongation factor 2 | 114.1 | 29.1 | 3.9 |
NM_005252 | FOS | V-fos FBJ murine osteosarcoma viral oncogene homolog | 483.5 | 100.4 | 4.8 |
NM_006732 | FOSB | FBJ murine osteosarcoma viral oncogene homolog B | 89.6 | 11.7 | 7.7 |
NM_015675 | GADD45B | Growth arrest and DNA-damage-inducible, beta | 87.5 | 19.3 | 4.5 |
NM_012483 | GNLY | Granulysin | 47.5 | 2.5 | 19.2 |
NM_006144 | GZMA | Granzyme A (granzyme 1, cytotoxic T-lymphocyte-associated serine esterase 3) | 15.3 | 4.5 | 3.4 |
NM_019111 | HLA-DRA | Major histocompatibility complex, class II, DR alpha | 226.5 | 33.9 | 6.7 |
NM_006895 | HNMT | Histamine N-methyltransferase | 13.4 | 4.4 | 3.1 |
NM_031157 | HNRPA1 | Heterogeneous nuclear ribonucleoprotein A1 | 31.8 | 8.8 | 3.6 |
NM_014365 | HSPB8 | heat shock 22-kDa protein 8 | 23.8 | 7.0 | 3.4 |
NM_000576 | IL1B | Interleukin 1, beta | 169.0 | 22.4 | 7.5 |
AK055991 | LAMR1 | Laminin receptor 1 (67 kDa, ribosomal protein SA) | 35.3 | 14.2 | 2.5 |
NM_002305 | LGALS1 | Lectin, galactoside-binding, soluble, 1 (galectin 1) | 15.5 | 4.3 | 3.6 |
X60188 | MAPK3 | Mitogen-activated protein kinase 3 | 228.5 | 81.3 | 2.8 |
NM_020529 | NFKBIA | Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | 705.4 | 56.0 | 12.6 |
NM_002135 | NR4A1 | Nuclear receptor subfamily 4, group A, member 1 | 46.0 | 15.4 | 3.0 |
NM_006186 | NR4A2 | Nuclear receptor subfamily 4, group A, member 2 | 35.7 | 9.5 | 3.8 |
U12767 | NR4A3 | Nuclear receptor subfamily 4, group A, member 3 | 18.3 | 4.4 | 4.2 |
BC011589 | OSM | Oncostatin M | 19.8 | 5.3 | 3.8 |
NM_002659 | PLAUR | Plasminogen activator, urokinase receptor | 23.8 | 4.8 | 4.9 |
NM_000311 | PRNP | Prion protein (p27-30) | 15.0 | 5.1 | 3.0 |
NM_000963 | PTGS2 | Prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) | 174.9 | 30.4 | 5.8 |
NM_002823 | PTMA | Prothymosin, alpha (gene sequence 28) | 169.0 | 56.0 | 3.0 |
NM_000994 | RPL32 | Ribosomal protein L32 | 174.4 | 58.6 | 3.0 |
NM_002966 | S100A10 | S100 calcium binding protein A10 (annexin II ligand, calpactin I, light polypeptide [p11]) | 33.9 | 9.2 | 3.7 |
NM_003745 | SOCS1 | suppressor of cytokine signaling 1, SSI-1 | 23.1 | 8.2 | 2.8 |
NM_032298 | SYT3 | synaptotagmin III, DKFZp761O132 | 30.2 | 11.4 | 2.7 |
NM_003246 | THBS1 | Thrombospondin 1 | 33.7 | 11.1 | 3.0 |
NM_006290 | TNFAIP3 | Tumour necrosis factor, alpha-induced protein 3 | 112.1 | 24.9 | 4.5 |
NM_003407 | ZFP36 | Zinc finger protein 36, C3H type, homolog (mouse) | 177.8 | 51.5 | 3.5 |